Direct Oral Anticoagulants: Overcoming the Challenges of Managing Venous Thromboembolism in Children
Medical writing support was provided by Geraint Owens, PhD, of Chameleon Communications International, with funding from Bayer AG. C.M. has received personal fees from Bayer AG, Boehringer Ingelheim, Bristol Myers Squibb, Janssen, and Pfizer, and fees paid to his institution from Bayer, Boehringer Ingelheim, Bristol Myers Squibb, and Pfizer. G.Y. has received honoraria and consulting payments from Bayer and Daiichi Sankyo. M.A. is a member of a pediatric expert working group for Boehringer Ingelheim and participated in advisory board activities of Daiichi Sankyo.
source https://www.jpeds.com/article/S0022-3476(21)00900-8/fulltext?rss=yes
source https://www.jpeds.com/article/S0022-3476(21)00900-8/fulltext?rss=yes
Comments
Post a Comment